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Transient Expression of Ephrin B2 in Perinatal Skin Is
Required for Maintenance of Keratinocyte
Homeostasis
Gyohei Egawa1,2, Masatake Osawa1,3, Akiyoshi Uemura1, Yoshiki Miyachi2 and Shin-Ichi Nishikawa1
The formation of functional skin entails multiple key signals that are implicated repeatedly in distinct processes
during embryogenesis. Although Eph receptors and their membrane-bound ephrin ligands play a role in a wide
variety of embryonic processes, their function in skin development has not been addressed. Here, we show that
ephrin B2 is transiently expressed in hair buds during embryogenesis and in dermal mesenchymal cells during
the perinatal period. Keratinocyte-specific ephrin B2-targeted mutant mice exhibit no skin phenotype, whereas
postnatal systemic ephrin B2 ablation results in the enhancement of keratinocyte proliferation. Although the
same treatment results in a defect of vascular remodeling, our analyses showed that the keratinocyte phenotype
is not caused by hypoxia due to vascular defects. Interestingly, we found an enhanced expression of IL-1
family molecules, which have been implicated in the regulation of keratinocyte proliferation. On the basis of
these observations, we propose that the transient expression of ephrin B2 in perinatal dermal mesenchymal
cells plays a role in adjusting the activity of the mesenchymal microenvironment that regulates proliferation of
keratinocytes.
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INTRODUCTION
The basic architecture of mouse skin, consisting of stratified
layers and hair follicles, is formed before birth, as the skin
constitutes the body’s first line of defense immediately after
birth. Formation of a functional skin requires an elaborate
differentiation process involving multiple key signals that
have also been implicated in other processes of embryogen-
esis. Wingless-related proteins and Sonic hedgehog have
been shown to be essential for follicle formation from a single
layer of embryonic ectoderm (Gat et al., 1998; St-Jacques
et al., 1998; DasGupta and Fuchs, 1999; Andl et al., 2002). In
contrast, signals from bone morphogenetic proteins and
fibroblast growth factors are involved in maintaining the
interfollicular epidermis, probably by inhibiting its conver-
sion to follicular keratinocytes (Jung et al., 1998; Noramly
and Morgan, 1998; Botchkarev et al., 1999; Atit et al., 2003).
It should be emphasized, however, that such a defense
line is not static. Skin and all its associated organs constitute a
constantly renewing dynamic system. Excessive proliferation
of the epidermis results in psoriasis, whereas insufficient
proliferation results in thin skin. The period immediately after
birth is one of the most precarious stages in an animal’s life,
as the environment surrounding the skin changes from
aminiotic fluid to air after birth. Thus, special mechanisms
may exist for regulating the proliferative activity of the
epidermis during the perinatal stage when the surrounding
environment changes drastically.
Eph receptor kinases and their membrane-bound ephrin
ligands form a complex signal network that is involved in
multiple processes during embryogenesis (Palmer and Klein,
2003; Pasquale, 2005). Eph receptors constitute a large family,
which is subdivided into subclass A (Epha1–a8) and subclass B
(Ephb1–b4, Ephb6) on the basis of sequence homology and
binding preferences. The ephrin ligands are also subdivided
into subclass A (Efna1–a5), which consists of ephrin ligands
that are tethered to the cell membrane by a glycosylpho-
sphatidylinositol anchor, and subclass B (Efnb1–b3), which
consists of transmembrane proteins with a cytoplasmic
domain. Ephrin A ligands typically bind to EphA receptors
and ephrin B ligands to EphB receptors. EphA4 has a broader
ligand-binding capacity and can bind the majority of ephrin A
ligands as well as ephrin B2 and ephrin B3 ligands.
Recent studies using gene-targeting technology have
enabled the identification of the processes in which Eph
receptor/ephrin signals are involved. Among the molecules in
this family, ephrin B2 is one of the most extensively studied,
particularly in terms of its function in angiogenesis (Wang
et al., 1998; Foo et al., 2006). Ephrin B2 is expressed
specifically in the arteries, whereas the expression of one of
its receptors, EphB4, is confined to the veins. In agreement
with this expression pattern, null mutation of either the ephrin
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B2 or the EphB4 gene results in the failure of vascular
remodeling (Gerety et al., 1999), suggesting that this signal
plays an essential role at the boundary of developing veins
and arteries in vascular morphogenesis.
However, ephrin B2 expression is not confined to the
vascular system. A series of studies has shown its roles in
somitogenesis and neural crest cell migration (Smith et al.,
1997; Santiago and Erickson, 2002; Barrios et al., 2003). The
functional role of the reverse signal has also been implicated
in the morphogenesis of urorectal tissues and osteoclast
differentiation (Dravis et al., 2004; Zhao et al., 2006).
Considering the diverse roles of ephrin B2 in multiple
tissues, it is somewhat surprising that its function in skin
development has not been addressed, although some studies
have analyzed its expression in human skin and in skin
tumors (Guo et al., 2006; Hafner et al., 2006). This
incomplete picture motivated us to investigate the function
of ephrin B2 in the development of skin. The aim of this study
was to investigate whether ephrin B2 plays a role in skin
morphogenesis. Here, we show that ephrin B2 is transiently
expressed in dermal mesenchymal cells during the perinatal
period and that it plays a role in regulating the proliferation
rate of epidermal cells.
RESULTS
Transient expression of ephrin B2 in the dermis during the
perinatal period
To investigate the possible involvement of ephrin B2 in skin
development, we first examined the expression of this
molecule in the skin from embryogenesis to the postnatal
period. To attain a high degree of sensitivity for detection, we
used the LacZ expression system in EphrinB2LacZ/þ mice,
which allows the detection of the endogenous expression of
ephrin B2 by the expression of LacZ (Wang et al., 1998).
Ephrin B2 expression was indeed detectable in mouse
skin; however, the localization of its expression varied
dramatically with age. During early embryogenesis, ephrin
B2 expression in the skin was first detectable in the
keratinocytes of the hair buds (Figure 1a and b). Subse-
quently, at E16.5, it was newly expressed in mesenchymal
cells (three to five cell layers) adjacent to the basal layer of
the epidermis (Figure 1c). Moreover, it was expressed in the
developing hair papilla, hair cortex, and sebaceous glands
(Figure 1d–f). Ephrin B2 expression in dermal mesenchymal
cells continued to approximately postnatal day (P) 20
and then disappeared (Figure 1g and h). Interestingly, this
loss of expression coincided with the commencement of the
Figure 1. The transition of ephrin B2 expression in the skin. (a) LacZ staining in an E14.5 EphrinB2LacZ/þ mouse embryo. Strong LacZ expression was
observed in hair buds and blood vessels. (b–i) Skin sections from EphrinB2LacZ/þ mice were stained with anti-LacZ antibody. Nuclear staining (blue) was with
TO-PRO3. Scale bar¼50 mm. (b) Ephrin B2 expression in embryonic skin. Arrowheads denote hair buds. (c) Double staining with antibodies against LacZ
(red) and a6-integrin (green). Ephrin B2 expression was detected just beneath the basal membrane. (d–i) Ephrin B2 expression in postnatal skin. The expression in
dermal mesenchymal cells is completely absent in (h) and (i).
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first hair cycle. In the later stage, strong ephrin B2 expression
in the skin was recognized only in the sebaceous glands
(Figure 1i).
Ephrin B2 expression in the epidermis is dispensable
Because the expression in the keratinocytes of embryonic
hair buds suggests that ephrin B2 plays a role in hair follicle
formation, we next attempted to conditionally delete the
ephrin B2 gene in epidermal keratinocytes. For this purpose,
we mated EphrinB2LoxP/LoxP mice with a keratin 14 (Krt14)-
Cre transgenic strain. To test the efficiency of gene ablation,
we examined the ratio of wild-type and mutant alleles in
keratinocytes of neonates of this strain. As expected, most
floxed alleles were deleted in the keratinocytes (Figure 2a).
On the other hand, no significant deletion was observed in
liver cells collected from the same mice. This result suggests
that keratinocyte-specific gene deletion worked efficiently.
However, we could not detect any overt defect in the
development and maintenance of dermal tissues including
those of hair follicles (Figure 2b). Thus, although ephrin B2 is
expressed in early hair buds, as well as in the sebaceous
glands of adults, it is dispensable for the development of
epidermal tissues.
Ephrin B2 in the dermis plays a role in the negative regulation of
epidermal cell proliferation
Next, we aimed at evaluating the functional significance of
ephrin B2 expression in dermal mesenchymal cells. Unlike
the case with keratinocytes, however, we were not aware of
an adequate method for depleting the ephrin B2 gene in this
specific region. Thus, we exploited a system that would
enable us to ablate the ephrin B2 gene stage specifically,
using tamoxifen-activatable Cre-recombinase, although this
treatment affects all lineages expressing ephrin B2 (Zhang
et al., 1996; Metzger and Chambon, 2001). The mouse strain
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Figure 2. Ablation of ephrin B2 at neonates exhibits skin abnormalities. (a) Efficient depletion of the ephrin B2 gene in the keratinocytes of Krt14-Cre;
EphrinB2LoxP/LoxP mice. Genomic DNA was extracted from the epidermis of Krt14-Cre; EphrinB2LoxP/LoxP mice and Cre-negative littermates (n¼3 each). As a
control, genomic DNA was extracted from the liver. Recombination efficiency was examined using real-time PCR. The results represent the mean±SD.
(b) Hematoxylin and eosin staining of skin sections from Krt14-Cre; EphrinB2LoxP/LoxP mice (right) and littermates (left) at postnatal day (P) 4. No significant
abnormality is detectable in the skin. Scale bar¼50 mm. (c) Genomic DNA was extracted from the skin of tamoxifen-treated CAG-MerCreMer; EphrinB2LoxP/LoxP
mice and Cre-negative littermates (n¼3 each). Recombination efficiency was examined by real-time PCR. The results represent the mean±SD. (d) CAG-
MerCreMer; EphrinB2LoxP/LoxP mice and Cre-negative littermates were treated with tamoxifen at P1. The skin phenotype at P9 is shown. (e–h) Hematoxylin and
eosin staining of skin sections from EphrinB2LoxP/LoxP (e, g) and CAG-MerCreMer; EphrinB2LoxP/LoxP mice (f, h). Both types of mice were treated with tamoxifen at
P1 and killed at P9. A high-magnification view is shown in (g) and (h). Significant hypercornification and thickening of the epidermis is observed in the
Cre-positive mouse.
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a chicken actin promoter–driven Cre-recombinase and two
mutated estrogen receptors (CAG–MerCreMer; Zhang et al.,
1996). To assess the role of ephrin B2 expression in dermal
mesenchymal cells, we injected tamoxifen on the first 2
neonatal days. The extent of ephrin B2 gene depletion was
confirmed by real-time PCR of cells prepared from skin. An
almost 90% deletion of the ephrin B2 gene was attained by
this treatment (Figure 2c). This treatment causes apparent
macroscopic phenotypes, including those of the skin. The
most conspicuous phenotypes were growth retardation and
flaky skin with retarded hair growth (Figure 2d). The skin
phenotype first appeared at P5 and peaked between 1 and 2
weeks after birth. Some pups were frail and subsequently
died; in other pups, however, normal skin was restored by
P20. Despite a general depression of vital activity, hypercor-
nification of the skin suggested an increased activity of the
keratinocyte layers. To determine the histological basis for
cornification, we carried out a series of histological analyses.
Consistent with the gross phenotype, an increase in
the thickness of the epidermis, shorter hair follicles, and a
thinner subcutis were observed to be the major defects
(Figure 2e–h).
Increased proliferation of the basal epidermal layer in ephrin
B2–deficient skin
To assess the effect of this treatment on keratinocyte
differentiation, the expression of various keratinocyte differ-
entiation markers was compared between the tamoxifen-
treated Cre-positive and -negative littermates. As shown in
Figure 3a–j, all molecular markers were expressed in the Cre-
positive mice. Moreover, except for the loricrin-positive layer,
the thickness of the cell layers expressing each epidermal
marker increased. This result strongly suggests that keratinocyte
differentiation per se is not affected by ephrin B2 deletion,
whereas there is a general increase in keratinocyte production.
We next assessed the proliferation rate of keratinocytes by
BrdU incorporation. The proportion of cells in the basal layer
of the epidermis incorporating BrdU was approximately
twofold higher in the Cre-positive group than in the controls
(Figure 3k). To examine whether hypercornification is due to
inflammatory reaction, we stained dermal tissues by mAb to a
pan-leukocyte antigen. As shown in Figure 3l, the infiltration
of leukocytes found in the Cre-positive animals was compar-
able with that of controls. Taken together, the tamoxifen-
induced deletion of ephrin B2 in the neonatal stage resulted
in hypercornification due to the enhanced proliferation of
epidermal progenitors.
Expression of ephrin B2–binding protein
Because EphB and EphA4 receptors have been implicated as
potential ephrin B2–binding counterparts (Pasquale, 2004),
we next determined the expression of these molecules by
subjecting cells harvested from neonatal skin to reverse
transcriptase-PCR and to immunohistochemical analyses.
Significant expression of all these Eph receptors, except
for EphB1, was detected by reverse transcriptase-PCR
(Figure 4a). Among these, we found that the expression of
EphA4 is complementary to that of ephrin B2 in the basal
layer of the epidermis and follicular keratinocytes (Figure 4b).
However, skin phenotypes were not observed in the EphA4-
targeted mutant mice (Dottori et al., 1998). Strong EphB4
expression was detected in a part of the blood vessels but not
in the area adjacent to the ephrin B2–positive dermal layer
(Figure 4c). Hence, it seems unlikely that EphB4 serves as the
binding protein for ephrin B2 in dermal mesenchymal cells.
Finally, to investigate the presence of proteins that can
bind to ephrin B2 in the vicinity of ephrin B2–positive cells,
we used ephrin B2-hFc, a chimeric protein that consists of the
extracellular part of ephrin B2 fused to the Fc portion of
human immunoglobulin. The EphA4-positive epidermal
basal layer was not stained by ephrin B2-hFc (Figure 4d and
e), presumably because of the low binding affinity, which
was shown to be approximately 10-fold less than that of
EphB1 or EphB2 (Gale et al., 1996). On the other hand, strong
staining was observed in the blood vessels, follicular
keratinocytes, and dermal mesenchyme. Ephrin B2-hFc–bind-
ing cells were CD45 negative, and some of them were
located in the vicinity of ephrin B2–positive dermal cells
(Figure 4f–h). EphA4-hFc selectively stained only the dermal
mesenchyme underlying the epidermis (Figure 4i). To confirm
the validity of this method, we also treated the same tissue
with EphB4-hFc, which stains ephrin B2–positive cells. As
expected, the dermal mesenchyme underlying the epidermis,
hair cortex, and blood vessels was stained (Figure 4j).
Likewise, EphA4-hFc, which can bind to ephrin B2, also
stained the dermal mesenchyme. Taken collectively, these
results indicate the presence of ephrin B2–binding counter-
parts in the vicinity of the ephrin B2–positive dermis. By the
process of elimination, we hypothesize that either EphB2 or
EphB3 is most likely to be present.
Vascular defects and the phenotype of the epidermis
Because ephrin B2 is essential for vascular morphogenesis,
we next investigated whether the ablation of ephrin B2 in
neonatal skin affects angiogenesis in the dermal tissues. The
vascular morphology in the dermis was severely affected in
the tamoxifen-treated mice. Histologically, this defect is
characterized by dilatation of the vascular lumen (Figure 5a).
To rule out the possibility that hypercornification is a result of
hypoxia due to a functional defect in the vascular system, we
investigated the occurrence of significant hypoxia in the
dermal region by comparing the gene expression profiles of
cells harvested from the skin of tamoxifen-treated Cre-
positive and -negative littermates. As shown in Figure 5b,
we did not detect a significant increase in molecules that are
known to be induced by hypoxia (Bedogni et al., 2005;
Hickey and Simon, 2006). Hence, the degree of dermal
vascular failure in this case was not high enough to result in
hypoxia of dermal tissues and therefore could not result in
hypercornification.
Enhanced expression of IL-1 family molecules in ephrin
B2–deficient animals
To identify upregulated genes in ephrin B2–targeted skin, we
conducted a comparative global transcription analysis using a
microarray (Table S1). Consistent with the results of our
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Figure 3. Keratinocyte differentiation is not affected, but the proliferation of keratinocytes is increased in ephrin B2–deficient neonates. (a–j) Immunohistochemical
analysis using keratinocyte differentiation markers. Skin sections from tamoxifen-treated CAG-MerCreMer; EphrinB2LoxP/LoxP mice (a–e) and Cre-negative littermates
(f–j) were stained with antibodies against keratin 5 (a, f), keratin 14 (b, g), keratin 10 (c, h), involcrin (d, i), and loricrin (e, j). All markers are detected in the skin of
Cre-positive mice. (k) Immunostaining with anti-BrdU antibody. CAG-MerCreMer; EphrinB2LoxP/LoxP mice (right) and Cre-negative littermates (left) were treated with
tamoxifen at postnatal day (P) 1 and received a BrdU injection at P6. High-magnification views are shown at the bottom left insets. BrdU-incorporating cells of the
interfollicular epidermis were counted in Cre-positive mice (open columns) and Cre-negative littermates (filled columns) at P6 and P9 (n¼ 4 each). A significant
increase of BrdU-incorporating cells is observed in tamoxifen-treated mice. The results represent the mean±SD. *Po0.05. Scale bar¼50mm. (l) Skin sections from
CAG-MerCreMer; EphrinB2LoxP/LoxP mice (right) and Cre-negative littermates (left) were stained with an antibody against CD45. CD45þ cells were counted in
Cre-positive mice (open columns) and Cre-negative controls (filled columns) at P7 (n¼ 3 each). The results represent the mean±SD. Scale bar¼ 50mm.
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previous assay (Figure 5b), hypoxia-induced molecules were
not increased in ephrin B2–targeted skin. Interestingly, the
levels of IL-1 family molecules were found to be significantly
increased, and we determined the expression level of these
molecules using quantitative RT-PCR (Figure 6a). Among
these, the expression of IL-1 family member 6 (IL-1F6) was
the most conspicuous (20.7±0.63-fold increase). We also
determined the expression pattern of IL-1F6 in the skin of
CAG-MerCreMer; EphrinB2LoxP/LoxP, and Cre-negative con-
trol mice (Figure 6b). Although IL-1F6 was expressed widely
in the dermis, including in the sheath of hair follicles, the
highest levels of expression were detected in the dermal
mesenchymal cells underlying the epidermal layers.
DISCUSSION
Whereas the Eph/ephrin signal plays a key role in morpho-
genesis, its role in the skin has been investigated only
superficially. In this study, we investigated ephrin B2
expression in dermal tissues by using a mouse strain that
bears an ephrin B2 allele into which the LacZ gene has been
Eph A4 B1 B2 B3 B4 B6
Figure 4. Expression of ephrin B2-binding proteins in the skin. (a) RT-PCR analysis of P4 C57BL/6N wild-type mice skin. The expression of Eph receptors that
can bind to ephrin B2 was examined. (b) EphA4 immunostaining in P4 wild-type skin. The basal layer of the epidermis is stained. (c) Skin sections from
EphB4LacZ/þ mice at postnatal day 6 were stained with anti-LacZ antibody. Arrowhead denotes EphB4 expression in blood vessels. (d, e) Detection of ephrin B2-
binding protens by staining with ephrin B2-hFc. P6 wild-type skin was incubated with ephrin B2-hFc (d) or control hFc protein (e). Arrowhead in (d) denotes a
blood vessel. Strong staining is observed in dermal mesenchymal cells. (f) P6 EphrinB2LacZ/þ mouse skin was incubated with ephrin B2-hFc and immunostained
with anti-LacZ antibody. (g, h) An ephrin B2-hFc–binding wild-type skin section was immunostained with anti-CD45 antibody. A high-magnification view is
shown in (h). Ephrin B2-hFc–binding cells (green) and CD45
þ cells (red) are different. (i) Detection of cells that bound to the EphA4-hFc protein. Only dermal
mesenchymal cells are stained. (j) Detection of cells that bound to the EphB4-hFc protein. P2 wild-type skin was incubated with EphB4-hFc. Arrowhead denotes
a blood vessel. Consistent with the data in Figure 1, dermal mesenchymal cells and blood vessels are stained by EphB4-Fc. Scale bar¼ 50mm.
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introduced (Wang et al., 1998). Using this highly sensitive
assay, we were able to detect ephrin B2 expression in three
sites of dermal tissues. The first site is the developing hair
buds during embryogenesis, the second is the perinatal
dermal mesenchymal cells located just beneath the epider-
mal layer, and the third is the sebaceous glands. Although
such a dynamic expression pattern per se is interesting in
terms of the gene regulatory mechanisms of ephrin B2, a
conditional ablation of ephrin B2 in Krt14-positive keratino-
cytes had no overt effect on the development of hair follicles
or sebaceous glands, both of which are derived from Krt14-
positive embryonic epidermis. On the other hand, total
ablation of ephrin B2 after birth resulted in a totally
unexpected phenotype—an increased proliferation of the
keratinocyte layer. Ephrin B2 is essential for vasculature
morphogenesis (Wang et al., 1998; Foo et al., 2006);
however, with respect to the dermal region, no notable sign
of a hypoxic reaction was detected in this skin, suggesting
that the overall function of the dermal vascular system is
maintained. Our analysis clearly showed that the hypercor-
nification is due to an enhancement of cell proliferation in the
basal layer, as assessed by BrdU incorporation, which results
in an increase of all keratinocyte layers. From this phenotype,
it is concluded that the transient expression of ephrin B2 in
perinatal dermal mesenchymal cells plays a role in the
suppression of keratinocyte overproliferation.
EphA4, which has been shown to bind to ephrin B2, is
expressed in the basal layer of the epidermis adjacent to the
ephrin B2-positive dermis, and EphA4-hFc specifically binds
to the subepidermal region. However, ephrin B2-hFc–binding
cells were not detected in the epidermis. We propose that this
discrepancy is due to the expression levels of EphA4 in the
epidermis, which are not strong enough to be detected by the
ephrin B2-hFc–binding assay used in this study. Another
possibility is that other types of ephrin ligands that can bind to
EphA4 were expressed in the subepidermal region. The
parsimonious interpretation of the complementary expression
pattern of ephrin B2 and EphA4 is that the expression of
EphA4, which is stimulated by ephrin B2 in the adjacent
mesenchymal cells, negatively regulates the proliferation of
keratinocytes. This is consistent with a previous study that
showed that EphA2 expressed in the epidermis is involved in
suppressing tumor formation in keratinocytes (Guo et al.,
2006). However, it remains unknown whether these two
molecules interact across the basement membrane because
both EphA4 and ephrin B2 are membrane-anchored proteins.
Moreover, skin phenotypes were not observed in EphA4-null
mutant mice (Gerety et al., 1999). In contrast, our search for
the ephrin B2–binding protein showed that such molecules
are also expressed in dermal mesenchymal cells and in cells
in vascular components. The localization of these cells
suggests that dermal mesenchymal cells are the most likely
candidates for interacting with ephrin B2-positive mesench-
ymal cells. If this assumption is correct, the hypercornifica-
tion cannot be an outcome of a cell-autonomous signaling
defect in keratinocytes. In contrast, the most likely possibility
is that cellular interaction between ephrin B2-positive
mesenchymal cells and mesenchymal cells exhibiting Eph
binding to ephrin B2 results in the secretion of molecules that
suppress the proliferation of keratinocytes.
Such an indirect mode of ephrin B2–dependent regulation
of cell proliferation would be unique. However, several
questions remain to be answered. First, which molecule is
involved in inducing the proliferation of keratinocytes? In this
study, we conducted a comparable global transcription
analysis by using a microarray and found that the expression
of IL-1 family molecules in the skin is enhanced after ablation
of the ephrin B2 gene. Among this family, the enhancement of
IL-1F6 expression is the most conspicuous. Indeed, previous
studies have shown that a set of IL-1 family molecules that
exert both positive and negative regulatory functions was
involved in maintaining the balance of keratinocyte prolifera-
tion (Bigler et al., 1992). At present, we cannot exclude the
possibility that the upregulation of such inflammatory
mediators is indirectly due to impaired skin barrier function.
However, we consider it likely that IL-1F6 is responsible, at
least partially, for the hypercornification because, in the
immunohistochemical analyses, IL-1F6 was particularly de-
tectable in the ephrin B2–positive mesenchymal cells under-
lying the epidermal layer. Moreover, a recent study has shown
that the overexpression of IL-1F6 results in the enhanced
proliferation of keratinocytes (Blumberg et al., 2007). On the
basis of these observations, we have concluded that the
ephrin B2 expressed in dermal mesenchymal cells during the
perinatal period is involved in suppressing the expression of
IL-1F6, thereby negatively regulating keratinocyte prolifera-
tion. Because keratinocyte proliferation, vascular dilatation,






Glut1 Car9 Hif1a Hif2a Vegfa Pdgfa Pdgfb Flt1 Flk2 Angpt2 Tie2
Figure 5. Absence of signs of hypoxia in the skin by conditional depletion
of ephrin B2. (a) Immunostaining with pan-endothelial antibody. CAG-
MerCreMer; EphrinB2LoxP/LoxP mice and Cre-negative littermates were treated
with tamoxifen at postnatal day (P) 1 and killed at P7. The dilatation of
blood vessels is observed in Cre-positive mice. Scale bar¼50 mm. (b)
Quantitative RT-PCR analysis of hypoxia-induced genes. CAG-MerCreMer;
EphrinB2LoxP/LoxP mice (open columns) and Cre-negative littermates (filled
columns) were treated with tamoxifen at P1 and killed at P7 (n¼ 4 each).
Relative expression levels compared with that of b-actin are shown. The
results represent the mean±SD.
2392 Journal of Investigative Dermatology (2009), Volume 129
G Egawa et al.
Ephrin B2 Regulates Proliferation of Keratinocytes
common skin phenotypes observed in psoriasis patients,
ephrin B2–positive mesenchymal cells may also interact with
and regulate the activity of immune cells. Future studies
should investigate the relationship between the pathology of
psoriasis and the function of ephrin B2.
The second question is which cells in the dermis are the
negative regulators of keratinocyte proliferation. We demon-
strated immunohistochemically that the highest expression of
IL-1F6 is detectable in dermal mesenchymal cells beneath the
epidermal layer, although lower expression is widely
observed in the dermis. Given that increased secretion of
IL-1F6 is involved in hypercornification, the most likely
scenario is that the ephrin B2–positive mesenchymal cells
beneath the epidermal layer regulate keratinocyte prolifera-
tion by adjusting the level of IL-1 family molecules in an
ephrin B2–dependent manner. It is important to note in this
context that both ephrin B2 and its partner EphB can serve as
receptors for signaling and as ligands. Judging from the
coincidental expression pattern of ephrin B2 and IL-1F6, it is
likely that ephrin B2 plays a role as a receptor mediating
reverse signaling rather than as a ligand of Eph.
Given that ephrin B2–dependent induction of a regulator
of keratinocyte proliferation is a mechanism maintaining the
balance of the keratinocyte production rate, the final question
is the biological significance of this mechanism in skin
development. The key observation with respect to this
question is that the ephrin B2 expression in the dermal
mesenchymal cells commences just before birth and con-
tinues throughout the perinatal period. Thus, this is likely to
be an auxiliary mechanism required for skin function during
the perinatal period. Parturition is the period when the
dermal tissue is exposed to a drastic microenvironmental
change—from the fetal state, when the skin is protected by
amniotic fluid, to the postnatal state, in which the skin is
directly exposed to the air. Thus, it is plausible that special
mechanisms may have developed to prepare for this stress
and that the ephrin B2–dependent regulation of keratinocyte
production is one such mechanism.
MATERIALS AND METHODS
Mice
EphrinB2LacZ/þ (B6. 129S7-Efnb2tm1And/J; Wang et al., 1998),
EphB4LacZ/þ (B6.129S7-Ephb4tm1And/J; Gerety et al., 1999), Ephrin-
B2LoxP/LoxP (B6.129S7-Efnb2tm2And; Gerety and Anderson, 2002), and
Krt14-Cre mice (STOCK Tg(KRT14-cre)1Amc/J, purchased from the
Jackson Laboratory Bar Harbor, ME; Dassule et al., 2000), were
backcrossed for more than five generations with C57BL/6N mice in
our laboratory for use in subsequent studies. To study the in vivo
function of ephrin B2, we bred EphrinB2LoxP/LoxP mice with Krt14-Cre
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Figure 6. IL-1 family molecules were increased in ephrin B2–deficient skin. (a) Quantitative RT-PCR analysis of IL-1 family molecules. CAG-MerCreMer;
EphrinB2LoxP/LoxP mice (open columns) and Cre-negative littermates (filled columns) were treated with tamoxifen at postnatal day (P) 1 and killed at P7 (n¼ 4
each). Relative expression levels compared with that of b-actin are shown. The increase in IL-1F6 is the most conspicuous among all, although a slight increase is
observed in other IL-1 family molecules. The results represent the mean±SD. *Po0.05. (b) Immunostaining with anti-IL-1F6 antibody. CAG-MerCreMer;
EphrinB2LoxP/LoxP mice and Cre-negative controls were treated with tamoxifen at P1 and killed at P7. A high-magnification view is shown in the right panel.
Expression is observed in the mesenchymal cells that express ephrin B2, and its expression is enhanced by ephrin B2 depletion. Scale bar¼ 50 mm.
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generated by injecting transgenic constructs that allow the expression
of MerCreMer (Zhang et al., 1996) under the control of the CAG
promoter into BDF1-fertilized eggs. The offspring were crossed with
C57BL/6N mice, and subsequent breeding was carried out on a
C57BL/6N background. All mouse experiments were performed in
accordance with the guidelines of the RIKEN Center for Develop-
mental Biology for animal and recombinant DNA experiments.
Tamoxifen treatment
To induce Cre-mediated recombination, CAG-MerCreMer; Ephrin-
B2LoxP/LoxP mice (0–2 days old) were treated with 4-hydroxytamox-
ifen (Sigma-Aldrich, St Louis, MO), administered by a single
intraperitoneal injection at a dosage of 200mg per mouse. The 4-
hydroxytamoxifen was dissolved in EtOH/corn oil (10mgml1). The
mice were killed 4–7 days after treatment.
b-galactosidase staining
Whole-mount b-galactosidase staining was carried out as described
previously (Mackenzie et al., 1997). Briefly, the embryos were fixed
with 4% paraformaldehyde for 30minutes to 1 hour and then stained
overnight with a halogenated indolyl-b-D-galactoside (Bluo-Gal;
Invitrogen, Carlsbad, CA) solution at 371C. The staining reaction was
stopped by washing in phosphate-buffered saline, and the embryos
were postfixed overnight in 4% paraformaldehyde at 41C.
Labeling experiment
CAG-MerCreMer; EphrinB2LoxP/LoxP mice and Cre-negative litter-
mates were treated with tamoxifen at P1. These mice received an
intraperitoneal injection of 100 mg g1 body weight 5-bromo-20-
deoxyuridine (BrdU; Sigma-Aldrich) at P6 or P9, 3 hours before
being killed. Immunohistochemical BrdU detection was carried out
as described below. For antigen retrieval, cryosections were
immersed in citric acid buffer (10mM, pH 6.0) and irradiated for
5minutes in a 600-W microwave oven.
Immunohistochemical staining
Immunostaining of neonatal skin was carried out as described
previously (Moriyama et al., 2006). Briefly, skin samples were
immersed in 4% paraformaldehyde, irradiated for 30 seconds in a
600-W microwave oven, and kept on ice for 30minutes. The fixed
skin was embedded in OCT compound, frozen, and then sectioned.
After treatment with Image-iT FX Signal Enhancer (Invitrogen), the
skin sections were incubated with primary antibodies diluted in
Blocking One (Nakarai-Tesque, Kyoto, Japan). The following
primary antibodies were used in the analysis: goat anti-b-gal
(Biogenesis, Mill Creek, WA, 1:500), rabbit anti-b-gal (Cappel,
Cochranville, PA, 1:500), rat anti-CD49f (Pharmingen, San Diego,
CA, 1:200), rat anti-CD45 (eBioscience, San Diego, CA 1:200),
rabbit anti-keratin 5 (Covance, Madison, WI, 1:500), FITC-
conjugated rabbit anti-keratin 14 (Covance, 1:1,000), rabbit anti-
keratin 10 (Covance, 1:500), rabbit anti-involcrin (Covance, 1:1,000),
rabbit anti-loricrin (Covance, 1:1,000), rat anti-BrdU (AbD Serotec,
Raleigh, NC, 1:50), goat anti-EphA4 (R&D Systems, Minneapolis, MN,
1:100), rabbit anti-pan-endothelial (Pharmingen, 1:200), and rat anti-
IL-1F6 (R&D Systems, 1:100). Fluorescent staining was carried out
using specific secondary antibodies conjugated to Alexa 488 or Alexa
546 (Invitrogen, 1:500). TO-PRO3 (Molecular Probes, Eugene, OR)
was used for nuclear staining. The slides were mounted using a
ProLong Antifade kit (Molecular Probes) and observed under a
confocal microscope (Zeiss, Carl Zeiss, Germany, LSM510 Meta).
Histochemical staining with hFc-chimeric proteins
Recombinant mouse ephrin B2-hFc, EphB4-hFc, EphA4-hFc, and
control hFc were purchased from R&D Systems. Staining with hFc-
chimeric protein was adapted from a previously described protocol
with minor modification (le Noble et al., 2004). Briefly, the dorsal skin
from P1–P6 neonates was dissected into small pieces in cold phosphate-
buffered saline and transferred to culture medium (Dulbecco’s
modified Eagle’s medium containing 10% fetal calf serum) for 1hour,
followed by incubation in culture medium containing 5mgml1 of
chimeric hFc or control hFc at 41C overnight. After being washed three
times in phosphate-buffered saline, the skin samples were fixed as
previously described and embedded in OCT compound. Cryosections
were treated with Image-iT FX Signal Enhancer (Invitrogen), followed by
incubation with FITC-conjugated anti-human Fc antibody (Covance,
1:500) diluted in Blocking One containing TO-PRO3.
RT-PCR and quantitative RT-PCR analysis
Total RNA from dorsal skin was purified using an RNeasy Mini kit
(Qiagen, Hilden, Germany). cDNA was synthesized using a Super-
Script first-strand cDNA synthesis kit (Invitrogen) with random
hexamers (Invitrogen) and purified using a QiaPrep spin column
(Qiagen) according to the manufacturer’s protocol. PCR analysis was
carried out using HS ExTaq DNA polymerase (TaKaRa, Ohtsu, Japan)
with 35 cycles of 30 seconds at 941C, 30 seconds at 551C, and
1minute at 721C. Quantitative PCR was carried out with an ABI
PRISM 7500 Sequence Detection System using a QuantiTech SYBR
Green PCR kit (Qiagen) according to the manufacturer’s protocol.
The relative expression of each gene was normalized against that of
b-actin. Most of the primer sequences were obtained from
PrimerBank (Wang and Seed, 2003). Details of the primers used in
these experiments are available on request.
Microarray analysis
The GeneChip Mouse Genome 430 2.0 array (Affymetrix, Santa
Clara, CA) was used to identify the differential expression of genes
between tamoxifen-treated CAG-MerCreMer; EphrinB2LoxP/LoxP mice
and Cre-negative littermates. Array hybridization, washing, and
scanning were carried out according to the manufacturer’s protocol
at the Functional Genome Unit of the RIKEN Center for Develop-
mental Biology. Scanned chip images were analyzed by using the
dChip software and GeneSpring software (Agilent, Santa Clara, CA)
to obtain model-based gene expression indices. A total of four chips
(two obtained from ephrin B2-targeted skin and two from control
skin) were used to develop the Perfect match/Miss-match model, and
the invariant set normalization method was applied. Pairwise
comparison was carried out, and the genes with a 90% lower
confidence bound of the fold change values that were above 2.0 in a
pair of samples were considered to be differentially expressed.
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